Ultralife appoints Janie Goddard as independent director

ULTRALIFE CORP

Janie Goddard appointed to Ultralife Board effective February 21, 2023.
Goddard is Divisional CEO at Halma plc; previously led at Novanta, Welch Allyn, Covidien, Johnson & Johnson.
She will serve on Audit & Finance, Compensation & Management, and Corporate Development & Governance committees.
Goddard also serves on the board of Methode Electronics (NYSE: MEI).
Compensation follows standard non-employee director terms per 2022 proxy statement.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Janie Goddard

independent director

ULBI · ULTRALIFE CORP

Effective: 2023-02-21
Filed: February 22, 2023, 6:59 PM ET

On February 21, 2023, the Board of Directors (the “Board”) of Ultralife Corporation (the “Company”) appointed Janie Goddard as an independent director of the Company effective as of February 21, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Janie Goddard was appointed as independent director at ULTRALIFE CORP.

Action: appointed
Role: independent director

Exact text from the filing

On February 21, 2023, the Board of Directors (the “Board”) of Ultralife Corporation (the “Company”) appointed Janie Goddard as an independent director of the Company effective as of February 21, 2023.

View on SEC.gov

ULTRALIFE CORP filing history →

Source: SEC EDGAR

accession 0001437749-23-004092

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.